A Win For Cidara Therapeutics, Inc.
Wed, Sep 06, 2023 at 08:41 PM
Cidara Therapeutics, Inc. (CDTX:NASDAQ) shot up at $1, a gain of 26.1%. On Wed, Sep 06, 2023, CDTX:NASDAQ touched a New 2-Week High of $1. The stock got featured on our News Catalysts scanner on Wed, Sep 06, 2023 at 04:18 PM in the 'MISCELLANEOUS' category. From Wed, Aug 23, 2023, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Tue, Mar 21, 2023 at $2.1 with a volume of 10M+.
About Cidara Therapeutics, Inc. (CDTX:NASDAQ)
Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, CloudbreakTM.
Top 10 Gainers:
- Palisade Bio Inc. (PALI:NASDAQ), 108.73%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 106.96%
- Power REIT (PW:NYSEMKT), 55.12%
- Theratechnologies Inc. (THTX:NASDAQ), 47.57%
- Marin Software Incorporated (MRIN:NASDAQ), 45.49%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 42.86%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 30.26%
- FLJ Group Limited (FLJ:NASDAQ), 28.24%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 26.07%
- Signature Bank (SBNY:NASDAQ), 25%